scholarly journals Bladder Cancer in an Inguinoscrotal Vesical Hernia

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Lucas Regis ◽  
Fernando Lozano ◽  
Jacques Planas ◽  
Juan Morote
Keyword(s):  
Adjuvant Radiotherapy ◽  
Bladder Tumor ◽  
Resection Margin ◽  
Diagnostic Delay ◽  
Subsequent Treatment ◽  
Pathology Report ◽  
Inguinoscrotal Hernia ◽  
Bladder Dome ◽  
Open Surgical Treatment ◽  
Anatomical Pathology

We present the case of a 79-year-old male who, due to hematuria, underwent cystoscopy that showed a lesion in the bladder dome. Transurethral resection was attempted, but access to the tumor by this route was impossible. Given the findings, a body CT scan was performed showing an inguinoscrotal hernia with vesical carcinoma contained. Open surgical treatment of the vesical carcinoma contained within the inguinoscrotal hernia was performed in conjunction with the hernia repair. The anatomical pathology report confirmed a high-grade urothelial carcinoma (stage pT2b) with a free resection margin of <1 mm. Adjuvant radiotherapy was selected for subsequent treatment. The presence of bladder tumor in an inguinoscrotal hernia is an uncommon finding and a diagnostic delay can be assumed. The initial therapeutic plan may need to be changed from the usual approaches due to the atypical presentation.

Improving the Quality of Surgical Pathology Reports for Breast Cancer: A Centralized Audit With Feedback

2008 ◽  
Vol 132 (9) ◽  
pp. 1428-1431
Author(s):  
Ronald Onerheim ◽  
Pierre Racette ◽  
André Jacques ◽  
Robert Gagnon
Keyword(s):  
Breast Cancer ◽  
Resection Margin ◽  
Lymphatic Invasion ◽  
Surgical Pathology ◽  
Breast Cancer Surgery ◽  
Pathology Report ◽  
Good Communication ◽  
Quality Of Reports ◽  
Pathology Reports

Abstract Context.—Good communication of pathologic characteristics of a malignancy is crucial to therapy choices and accurate prognostication. The information must be easily retrieved from a surgical pathology report. Objectives.—To evaluate, first in 1999, the quality of surgical pathology reports for segmental breast resections for cancer in Quebec hospitals. Subsequently, to reevaluate, in 2003, the same indicators to determine if the first surveillance, with feedback, was associated with an improvement in the quality of the reports. Design.—All Quebec hospitals performing the preset number of 20 or more segmental breast resections for cancer in 1999 and 2003 participated. A committee of pathologists, after review of the literature, chose 7 diagnostic elements deemed vital to a surgical pathology report for conservative breast cancer surgery. Medical archivists in each institution were instructed on how to retrieve the data. The main outcome measure was the presence or absence of the diagnostic information clearly presented on the surgical pathology report. Results.—Fifty-one hospitals participated in 1999 and 50 in 2003. Overall, conformity improved from 85.0% in 1999 for the first evaluation to 92.5% in 2003 for the second evaluation (P &lt; .001). Six of the 7 indicators showed an improvement in the level of conformity between the first and second evaluations. Conformity was weakest for recording the distance between the tumor and the resection margin (68.2%) and vascular/lymphatic invasion (61.4%) in 1999. Conclusions.—Surveillance of quality of surgical pathology reports, with feedback, is significantly associated with an improvement in the quality of reports.

The Result of Re-Transurethral Resection of Bladder Tumor in Eight Years

2021 ◽  
Vol 104 (9) ◽  
pp. 1411-1414
Keyword(s):  
Transurethral Resection ◽  
Bladder Tumor ◽  
Residual Tumor ◽  
Pathology Report ◽  
Detrusor Muscle ◽  
Incomplete Resection ◽  
High Grade ◽  
Recurrence Free Survival ◽  
Minor Complication ◽  
Free Survival

Objective: To analyses the residual tumor and staging after transurethral resection of bladder tumor (TURBT). Moreover, to analyze the recurrence and free survival patients who received treatment by re-transurethral resection of bladder tumor (RE-TURBT) and their complications. Materials and Methods: A retrospective study from 35 patients operated by RE-TURBT between January 2010 and December 2018 was done. The patients in the present study were qualified by 1) incomplete resection from the first TURBT, 2) the detrusor muscle did not appear in specimen for high grade transition cell carcinoma, 3) any T1 lesion, or 4) large or multifocal lesion. The analysis of the residual tumor included staging, recurrence-free survival, and complication after RE-TURBT from the pathology report and follow up method. Results: Thirty-five patients were included in this study. The average age of the patients operated by RE-TURBT was 69 years old, with a range of 44 to 87 years old. The presenting symptom was hematuria with gross hematuria in 28 patients (80%) and microhematuria in seven patients (20%). Twenty-five patients (71.4%) were male. The relative factor was smoking in 23 patients (65%) and coexisting with irritative voiding symptom in 11 patients (31.4%). The present study found that there was incomplete resection in 11 patients (31.4%), with under-staging in five patients and incomplete resection in six patients. There were 14 months recurrence-free survival and minor complication in RE-TURBT patients. Conclusion: One third of the patients operated by RE-TURBT had unreasonable staging, especially in Ta high grade staging. This could change the treatment in two patients (5.7%), which found minor complication from RE-TURBT, and improve recurrence-free survival. Keywords: Transurethral resection of bladder tumor (TURBT); Re Transurethral resection of bladder tumor (Re-TURBT)

Margin Clearance and Outcome in Resected Pancreatic Cancer

2009 ◽  
Vol 27 (17) ◽  
pp. 2855-2862 ◽  
Author(s):  
David K. Chang ◽  
Amber L. Johns ◽  
Neil D. Merrett ◽  
Anthony J. Gill ◽  
Emily K. Colvin ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Clinical Trials ◽  
Adjuvant Radiotherapy ◽  
Resection Margin ◽  
Resection Margins ◽  
Term Survival ◽  
Long Term Survival ◽  
Operative Resection ◽  
Occult Metastatic Disease

Purpose Current adjuvant therapies for pancreatic cancer (PC) are inconsistently used and only modestly effective. Because a high proportion of patients who undergo resection for PC likely harbor occult metastatic disease, any adjuvant trials assessing therapies such as radiotherapy directed at locoregional disease are significantly underpowered. Stratification based on the probability (and volume) of residual locoregional disease could play an important role in the design of future clinical trials assessing adjuvant radiotherapy. Patients and Methods We assessed the relationships between margin involvement, the proximity to operative resection margins and outcome in a cohort of 365 patients who underwent operative resection for PC. Results Microscopic involvement of a resection margin by tumor was associated with a poor prognosis. Stratifying the minimum clearance of resection margins by 0.5-mm increments demonstrated that although median survival was no different to clear margins based on these definitions, it was not until the resection margin was clear by more than 1.5 mm that optimal long-term survival was achieved. Conclusion These data demonstrate that a margin clearance of more than 1.5 mm is important for long-term survival in a subgroup of patients. More aggressive therapeutic approaches that target locoregional disease such as radiotherapy may be beneficial in patients with close surgical margins. Stratification of patients for entry onto future clinical trials based on this criterion may identify those patients who benefit from adjuvant radiotherapy.

Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: progress pathology report of the Italian PROSIT study

Urology ◽  
2001 ◽  
Vol 57 (1) ◽  
pp. 117-121 ◽  
Author(s):  
Aldo V. Bono ◽  
Francesco Pagano ◽  
Rodolfo Montironi ◽  
Filiberto Zattoni ◽  
Antonio Manganelli ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Resection Margin ◽  
Margin Status ◽  
Pathology Report ◽  
Pathologic Stage ◽  
Resection Margin Status ◽  
Complete Androgen Blockade ◽  
Androgen Blockade

scholarly journals Ectopic Prostate Tissue at the Bladder Dome Presenting as a Bladder Tumor

2013 ◽  
Vol 31 (2) ◽  
pp. 176 ◽  
Author(s):  
Jae Heon Kim ◽  
Yoon Mi Jeen ◽  
Yun Seob Song
Keyword(s):  
Bladder Tumor ◽  
Prostate Tissue ◽  
Bladder Dome

scholarly journals Dermatofibrosarcoma Protuberans and Adjuvant Radiotherapy: A Case Report with Uncertain Surgical Margins in The Breast

2021 ◽  
pp. 342-349
Author(s):  
Alaettin Arslan ◽  
Saliha Karagoz Eren ◽  
Serdal Sadet Ozcan ◽  
Ebru Akay ◽  
Mustafa Ozdemir
Keyword(s):  
Adjuvant Radiotherapy ◽  
Surgical Margin ◽  
Dermatofibrosarcoma Protuberans ◽  
Residual Tumor ◽  
Primary Treatment ◽  
The Body ◽  
Surgical Margins ◽  
Pathology Report ◽  
Tumor Diameter ◽  
Margin Of Safety

Background: Dermatofibrosarcoma Protuberans (DFSP) is a rare, locally aggressive superficial soft tissue tumor that can occur in many parts of the body. Surgical resection with a wide margin of safety is the main treatment modality of this rare tumor of the breast. According to the postoperative pathology report, the patient can be followed up or adjuvant radiotherapy (RT) can be added.  Case presentation: A 22-year-old woman presented with a mass filling the lower inner quadrant of her right breast. Tru-cut biopsy revealed a mesenchymal tumor, but excision was recommended for definitive diagnosis. A right breast quadrantectomy was performed. The result came as DFSP. Tumor diameter was 10x9x6.5 cm and the tumor was positive in most of the surgical margins. The patient underwent re-resection and a residual tumor with a diameter of 0.2 cm was detected at a distance of 3.3 cm from the surgical margin. Although the surgical margins were negative, the distance of the posterior surgical margin, in particular, could not be assured. Because of the uncertainty of surgical margins, 60 Gy RT was planned. Conclusion: The localization of DFSP in the breast is extremely rare and surgery is the primary treatment. RT should be added as an adjuvant when safe surgical margins cannot be obtained.

Sign in / Sign up

Export Citation Format

Share Document